| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
USA. FDA Approves First Nalmefene Auto-Injector for Opioid Overdose
USA. FDA Approves First Nalmefene Auto-Injector for Opioid Overdose
The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people aged 12 years or older. (Medscape, USA, 08.08.2024)
https://www.medscape.com/viewarticle/fda-approves-first-nalmefene-auto-injector-opioid-overdose-2024a1000emy